Endocan, a new invasion and angiogenesis marker of pituitary adenomas

Journal of Neuro-Oncology

Volumn 117, Issue 3, 2014, Pages 485-491

  Matano, Fumihiro ^a   Yoshida, Daizo ^a   Ishii, Yudo ^a   Tahara, Shigeyuki ^a   Teramoto, Akira ^a   Morita, Akio ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Endocan; Tumor angiogenesis; Tumor invasion; Vascular endothelial cell

Indexed keywords

CD34 ANTIGEN; CORTICOTROPIN; ENDOCAN; GROWTH HORMONE; PROLACTIN; THYROTROPIN; TUMOR MARKER; UNCLASSIFIED DRUG; ESM1 PROTEIN, HUMAN; PROTEOGLYCAN; TUMOR PROTEIN;

ACTH SECRETING ADENOMA; ADULT; AGE; ANGIOGENESIS; ARTICLE; CAVERNOUS SINUS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FEMALE; GENDER; GROWTH HORMONE SECRETING ADENOMA; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROADENOMA; NONFUNCTIONING PITUITARY ADENOMA; PROLACTINOMA; PROTEIN EXPRESSION; THYROTROPIN SECRETING ADENOMA; TUMOR INVASION; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM; DIAGNOSTIC USE; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; PITUITARY NEOPLASMS;

ANTIGENS, CD34; ENDOTHELIAL CELLS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PITUITARY NEOPLASMS; PROTEOGLYCANS; TUMOR MARKERS, BIOLOGICAL;

EID: 84901285655     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-014-1377-6     Document Type: Article

References (30)

1. Di Ieva A, Grizzi F, Ceva-Grimaldi G, Aimar E, Serra S, Pisano P, Lorenzetti M, Tancioni F, Gaetani P, Crotti F, Tschabitscher M, Matula C, Rodriguez YBR (2010) The microvascular network of the pituitary gland: a model for the application of fractal geometry to the analysis of angioarchitecture and angiogenesis of brain tumors. J Neurosurg Sci 54:49-54
2. Di Ieva A, Weckman A, Di Michele J, Rotondo F, Grizzi F, Kovacs K, Cusimano MD (2013) Microvascular morphometrics of the hypophysis and pituitary tumors: from bench to operating theatre. Microvasc Res 89:7-14. doi:10.1016/j.mvr.2013.04.009
3. Jasek E, Furgal-Borzych A, Lis GJ, Litwin JA, Rzepecka-Wozniak E, Trela F (2009) Microvessel density and area in pituitary microadenomas. Endocr Pathol 20:221-226. doi:10.1007/s12022-009-9091-1
4. Lee JS, Park YS, Kwon JT, Nam TK, Lee TJ, Kim JK (2011) Radiological apoplexy and its correlation with acute clinical presentation, angiogenesis and tumor microvascular density in pituitary adenomas. J Korean Neurosurg Soc 50:281-287. doi:10.3340/jkns.2011.50.4.281
5. Zhang Y, He N, Zhou J, Chen Y (2011) The relationship between MRI invasive features and expression of EMMPRIN, galectin-3, and microvessel density in pituitary adenoma. Clin Imaging 35:165-173. doi:10.1016/j.clinimag.2010.06. 002
6. Yamada S, Takada K (2003) Angiogenesis in pituitary adenomas. Microsc Res Tech 60:236-243. doi:10.1002/jemt.10262
7. Nomura R, Yoshida D, Teramoto A (2009) Stromal cell-derived factor-1 expression in pituitary adenoma tissues and upregulation in hypoxia. J Neurooncol 94:173-181. doi:10.1007/s11060-009-9835-2
8. Abid MR, Yi X, Yano K, Shih SC, Aird WC (2006) Vascular endocan is preferentially expressed in tumor endothelium. Microvasc Res 72:136-145. doi:10.1016/j.mvr.2006.05.010
9. Grigoriu BD, Depontieu F, Scherpereel A, Gourcerol D, Devos P, Ouatas T, Lafitte JJ, Copin MC, Tonnel AB, Lassalle P (2006) Endocan expression and relationship with survival in human nonsmall cell lung cancer. Clin Cancer Res Off J Am Assoc Cancer Res 12:4575-4582. doi:10.1158/1078-0432.ccr-06-0185
10. Sarrazin S, Adam E, Lyon M, Depontieu F, Motte V, Landolfi C, Lortat-Jacob H, Bechard D, Lassalle P, Delehedde M (2006) Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Biochim Biophys Acta 1765:25-37. doi:10.1016/j.bbcan.2005.08.004
11. Scherpereel A, Depontieu F, Grigoriu B, Cavestri B, Tsicopoulos A, Gentina T, Jourdain M, Pugin J, Tonnel AB, Lassalle P (2006) Endocan, a new endothelial marker in human sepsis. Crit Care Med 34:532-537
12. Cornelius A, Cortet-Rudelli C, Assaker R, Kerdraon O, Gevaert MH, Prevot V, Lassalle P, Trouillas J, Delehedde M, Maurage CA (2012) Endothelial expression of endocan is strongly associated with tumor progression in pituitary adenoma. Brain Pathol 22:757-764. doi:10.1111/j.1750-3639.2012.00578.x
13. Filep JG (2006) Endocan or endothelial cell-specific molecule-1: a novel prognostic marker of sepsis? Crit Care Med 34:574-575
14. Maurage CA, Adam E, Mineo JF, Sarrazin S, Debunne M, Siminski RM, Baroncini M, Lassalle P, Blond S, Delehedde M (2009) Endocan expression and localization in human glioblastomas. J Neuropathol Exp Neurol 68:633-641. doi:10.1097/NEN.0b013e3181a52a7f
15. Rennel E, Mellberg S, Dimberg A, Petersson L, Botling J, Ameur A, Westholm JO, Komorowski J, Lassalle P, Cross MJ, Gerwins P (2007) Endocan is a VEGF-A and PI3 K regulated gene with increased expression in human renal cancer. Exp Cell Res 313:1285-1294. doi:10.1016/j.yexcr.2007.01.021
16. Zuo L, Zhang SM, Hu RL, Zhu HQ, Zhou Q, Gui SY, Wu Q, Wang Y (2008) Correlation between expression and differentiation of endocan in colorectal cancer. World J Gastroenterol WJG 14:4562-4568
17. Huang GW, Tao YM, Ding X (2009) Endocan expression correlated with poor survival in human hepatocellular carcinoma. Dig Dis Sci 54:389-394. doi:10.1007/s10620-008-0346-3
18. Hatfield KJ, Lassalle P, Leiva RA, Lindas R, Wendelboe O, Bruserud O (2011) Serum levels of endothelium-derived endocan are increased in patients with untreated acute myeloid leukemia. Hematology (Amsterdam, Netherlands) 16:351-356. doi:10.1179/102453311x13127324303434
19. Zhang S, Zuo L, Gui S, Zhou Q, Wei W, Wang Y (2012) Induction of cell differentiation and promotion of endocan gene expression in stomach cancer by melatonin. Mol Biol Rep 39:2843-2849. doi:10.1007/s11033-011-1043-4
20. El Behery MM, Seksaka MA, Ibrahiem MA, Saleh HS, El Alfy Y (2013) Clinicopathological correlation of endocan expression and survival in epithelial ovarian cancer. Arch Gynecol Obstet. doi:10.1007/s00404-013-2863-3
21. Mikkelsen ME, Shah CV, Scherpereel A, Lanken PN, Lassalle P, Bellamy SL, Localio AR, Albelda SM, Meyer NJ, Christie JD (2012) Lower serum endocan levels are associated with the development of acute lung injury after major trauma. J Crit Care 27(522):e511-e527. doi:10.1016/j.jcrc.2011.07.077
22. Zhang SM, Zuo L, Zhou Q, Gui SY, Shi R, Wu Q, Wei W, Wang Y (2012) Expression and distribution of endocan in human tissues. Biotechnic Histochem Off Publ Biol Stain Comm 87:172-178. doi:10.3109/10520295.2011.577754
23. Balta I, Balta S, Demirkol S, Mikhailidis DP, Celik T, Akhan M, Kurt O, Kurt YG, Aydin I, Kilic S (2013) Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease. Br J Dermatol. doi:10.1111/bjd.12525
24. De Freitas Caires N, Legendre B, Parmentier E, Scherpereel A, Tsicopoulos A, Mathieu D, Lassalle P (2013) Identification of a 14 kDa endocan fragment generated by cathepsin G, a novel circulating biomarker in patients with sepsis. J Pharm Biomed Anal 78-79:45-51. doi:10.1016/j.jpba.2013.01.035
25. Nault JC, Guyot E, Laguillier C, Chevret S, Ganne-Carrie N, N'Kontchou G, Beaugrand M, Seror O, Trinchet JC, Coelho J, Lassalle P, Charnaux N, Delehedde M, Sutton A, Nahon P (2013) Serum proteoglycans as prognostic biomarkers of hepatocellular carcinoma in patients with alcoholic cirrhosis. Cancer Epidemiol Biomark Prev. doi:10.1158/1055-9965.epi-13-0179
26. Roudnicky F, Poyet C, Wild P, Krampitz S, Negrini F, Huggenberger R, Rogler A, Stohr R, Hartmann A, Provenzano M, Otto VI, Detmar M (2013) Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis. Cancer Res 73:1097-1106. doi:10.1158/0008-5472.can- 12-1855
27. Pizarro CB, Oliveira MC, Pereira-Lima JF, Leaes CG, Kramer CK, Schuch T, Barbosa-Coutinho LM, Ferreira NP (2009) Evaluation of angiogenesis in 77 pituitary adenomas using endoglin as a marker. Neuropathology Off J Jpn Soc Neuropathol 29:40-44. doi:10.1111/j.1440-1789.2008.00937.x
28. Yoshida D, Nomura R, Teramoto A (2009) Signalling pathway mediated by CXCR7, an alternative chemokine receptor for stromal-cell derived factor-1alpha, in AtT20 mouse adrenocorticotrophic hormone-secreting pituitary adenoma cells. J Neuroendocrinol 21:481-488. doi:10.1111/j.1365-2826.2009.01867.x
29. Yoshida D, Koketshu K, Nomura R, Teramoto A (2010) The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells. J Neurooncol 100:51-64. doi:10.1007/s11060-010-0152-6
30. Viacava P, Gasperi M, Acerbi G, Manetti L, Cecconi E, Bonadio AG, Naccarato AG, Acerbi F, Parenti G, Lupi I, Genovesi M, Martino E (2003) Microvascular density and vascular endothelial growth factor expression in normal pituitary tissue and pituitary adenomas. J Endocrinol Invest 26:23-28